1 / 29

Echo Conference

Echo Conference. Cardiology Cardiomyopathy. Cardiomyopathy. Echo Evaluation of Cardiomyopathies Dilated CM-dilation and reduced contractility of LV/RV Hypertrophic CM- Hypertrophy of the LV Restrictive CM-Restrictive diastolic filling and dec diastolic volume

haile
Download Presentation

Echo Conference

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Echo Conference Cardiology Cardiomyopathy

  2. Cardiomyopathy • Echo Evaluation of Cardiomyopathies • Dilated CM-dilation and reduced contractility of LV/RV • Hypertrophic CM- Hypertrophy of the LV • Restrictive CM-Restrictive diastolic filling and dec diastolic volume • Arrhythmogenic RV CM (AVRC/AVRD)-Fibrofatty replacement of the RV myocardium • Non-compaction-Extensive trabeculation of the ventricular wall • Takasubo-stress induced • Ischemic CM-2/2 CAD

  3. Cardiomyopathy • Dilated Cardiomyopathy • Normal LV diastolic diameter is less than 5.6cm • Incidence of dilated CM • 5 to 8 cases per 100,000 • Prevalence of 36 per 100,000 • Up to 14 percent of adults may have asymptomatic • Common causes • Viral, HIV, Chagas, Lyme, alcohol, Cocaine, Meds, Peripartum, Tachycardia-mediated, Sarcoid, ESRD, Autoimmune, OSA

  4. Cardiomyopathy • Dilated Cardiomyopathy • 1) dilated LV cavity • Sphericity index – nml >1.5 (100/86=1.16) • 2) decreased global systolic function

  5. Cardiomyopathy • Dilated CM – Diastolic Dysfunction-pseudonormal

  6. Cardiomyopathy • Hypertrophic Cardiomyopathy • Genetic disorder – 10 genes • 1 in 500 phenotypic expression • Asymmetric septal – most common • Concentric, Apical, or free wall LV hypertrophy • Sudden death cummulative • 19mm – 0% • 30mm – 40% • 2D echo

  7. Cardiomyopathy • Hypertrophic Cardiomyopathy

  8. Cardiomyopathy • Hypertrophic CM – Myocyte disarray

  9. Cardiomyopathy • Hypertrophic CM – Long Axis – LVOT obstruction

  10. Cardiomyopathy • Hypertrophic CM – Short Axis

  11. Cardiomyopathy • Hypertrophic CM – Systolic Anterior Motion – M-mode

  12. Cardiomyopathy • Hypertrophic CM – Doppler • LVOT gradient >30mmHg

  13. Cardiomyopathy • Athlete’s Heart vs Hypertrophic • 1) More symmetrical • 2) Rarely more than 17mm • 3) LV dimenstion is increased vs decreased • 4) Diastolic function nml (E’ > 7cm/s) • 5) Tissue doppler and strain normal

  14. Cardiomyopathy • Apical Hypertrophic Cardiomyopathy

  15. Cardiomyopathy • Restrictive Cardiomyopathy • Restricted ventricular filling 2/2 nonhypertrophiednondilated myocardial abnormality • Stiffening fibrosis • Decreased compliance • Nml EF, nml LV cavities, nml wall thickness, w/ BAE • Restrictive filling pattern grade 3 or 4 • Dip-and-plateau or square root in diastolic pressure trace

  16. Cardiomyopathy • Restrictive Cardiomyopathy • Causes include • Infiltrative-amyloidosis, sarcoidosis • Non-infiltrative-familial, idiopathic • Storage diseases-hemochromatosis, Fabry • Endomyocardial diseases-endomyocardial fibrosis, hypereosinophilic syndrome (scarring) • Radiation or drug toxicity (anthracycline)

  17. Cardiomyopathy • Restrictive CM – 3 Doppler features • 1) Mitral and Tricuspid inflow • Inc E velocity: >1 m/s • Dec A velocity: <0.5 m/s • Ratio E/A >2.0 • Short DT <160 and Decreased IVRT <70

  18. Cardiomyopathy • Restrictive CM – 3 Doppler features • 2) Pulmonary and hepatic vein flow • Systolic velocity less than diastolic velocity • Increased hepatic diastolic flow reversal in inspiration • Increased pulmonary vein atrial flow reversal velocity

  19. Cardiomyopathy • Restrictive CM – 3 Doppler features • 3) Tissue Doppler • Decreased systolic velocity: s’ < 5cm • Decreased early diastolic velocity: E’ < 7cm/s

  20. Cardiomyopathy • Right Ventricular Dysplasia/Cardiomyopathy • ARVD • Progressive replacement of the RV myocardium by fatty and fibrous tissue • Present with LBBB, CHF, murmur, or sudden death • In Europe, MCC cardiac death young pt (1/3) • Autosomal dominant • EKG epsilon wave V1-3

  21. Cardiomyopathy • Right Ventricular Dysplasia/Cardiomyopathy • Echo findings • RVOT diameter >25mm, best PLAX RVOT >30mm • Abnml RV function • RV regional wall motion abnormalities (apex and ant) • RV travecular derangements, hyperreflective moderator band

  22. Cardiomyopathy

  23. Cardiomyopathy • Non-compaction Cardiomyopathy • Embryonic arrest of compaction • Segmental thickening of LV wall with two layers • Ratio greater than 2 • LV cavity enlarged • LV ejection fraction decreased • c/b heart failure, thrombosis, VT, and sudden death

  24. Cardiomyopathy • Non-compaction Cardiomyopathy • Ratio 2:1

  25. Cardiomyopathy • Takosubo Cardiomyopathy • Stress-induced CM • Apical ballooning syndrome • Broken heart syndrome • Mimics MI but no evidene of obstructive CAD • Octopus trap • Triggers – medical illness, emotional, physical stress • Etiology – unclear, • postulate catecholamine excess • Coronary spasm • Microvascular dysfunction

  26. Cardiomyopathy • Takosubo Cardiomyopathy

  27. Cardiomyopathy • Ischemic Cardiomyopathy • Significant impaired left ventricular function <35-40% • 2/2 coronary artery disease • Most common cause of heart failure in developed world • Management of ischemic cardiomyopathy • Evaluation of the coronary artery disease • Medical management similary to nonischemic CM • Also device related strategies

  28. Questions

  29. blank • blank

More Related